# Oliver Heimes

> Oliver Heimes is a Series A investor at Lakestar (Zürich) backing Health Care and Software. See 21 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lakestar](https://shizune.co/investors/profile/lakestar)
- Location: Zürich, Switzerland
- Total investments: 21
- Last investment: Jan 2026
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/oahzrh/

Oliver Heimes is a Series A investor at Lakestar in Zürich focused on Health Care and Software. Oliver is a Partner at Lakestar and has been part of the team since 2011, prior to the inception of Lakestar's first fund in 2013.Oliver focuses mainly on Lakestar’s US-based activities with early stage / Series A investments in companies such as Oscar Health, Cedar, Aetion, Truemotion, Auterion and Harrys. He is on the board ofAuterion. In 2017, he was elected Forbes 30 under 30.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 29% |
| Software | 3 | 14% |
| Medical | 2 | 10% |
| Internet | 2 | 10% |
| Payments | 2 | 10% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 19% |
| Series B | 4 | 19% |
| Pre-Seed | 2 | 10% |
| Series C | 2 | 10% |
| Funding Round | 2 | 10% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 4 | 19% |
| Germany | 3 | 14% |
| United Kingdom | 2 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GeneralMind | GeneralMind is an AI company that reduces repetitive supply-chain operations by automating manual steps in email, excel, and ERP systems with a human-powered autopilot. | $12M | Pre-Seed | Jan 20, 2026 |  |
| Nelly | Nelly provides a tool for medical practices that simplifies patient onboarding and payments. It creates the basis for stress-free and clear work in your practice by drastically reducing the administrative effort for doctors, MFAs, ZFAs, and patients with Nelly. 90% of all healthcare professionals perceive bureaucracy and administrative burdens asthe biggest problem in the workplace.The company's mission is to reduce the administrative effort in the healthcare sector by simplifying documentation and payment processes in order to make the practice visit more patient- and employee-friendly. | $51.5M | Series B | Jan 14, 2025 |  |
| Doccla | Doccla is the virtual ward company. We are the pioneers of tech-agnostic virtual wards. We partner with care organisations to enable early discharge and prevent hospital readmission by monitoring patients remotely using best of breed devices. Doccla’s Covid-19 support service evolved from a research project we were running for the NHS, and wasdesigned collaboratively with Northampton General Hospital, where the service is now in live use. | $46M | Series B | Sep 02, 2024 |  |
| Bluprynt | Bluprynt is a company that provides digital asset declaration services to improve compliance and safety in the process. The company provides disclosure infrastructure and compliance technologies, as well as identifying and guiding government trends and market expectations, allowing businesses to save time and focus on core activities. | $1.7M | Pre-Seed | May 15, 2024 |  |
| Nelly | Nelly provides a tool for medical practices that simplifies patient onboarding and payments. It creates the basis for stress-free and clear work in your practice by drastically reducing the administrative effort for doctors, MFAs, ZFAs, and patients with Nelly. 90% of all healthcare professionals perceive bureaucracy and administrative burdens asthe biggest problem in the workplace.The company's mission is to reduce the administrative effort in the healthcare sector by simplifying documentation and payment processes in order to make the practice visit more patient- and employee-friendly. | $16.4M | Series A | Jun 15, 2023 |  |
| Aware | Aware is a mobile app for evaluating health data and for researching chronic diseases. | $15M | Seed | Jun 27, 2022 |  |
| Accurx | Accurx is where conversations happen with and about patients. Through one, easy-to-use platform, we help everyone involved in a patient’s care to communicate and collaborate.Whether you’re a patient or a healthcare professional, Accurx lets you connect seamlessly with the people you need to. You can use Accurx to: send SMS messages and medicalsurveys, provide appointment reminders and referrals, hold video consultations, and manage virtual wards, outpatient clinics and follow-up pathways.Accurx is used by 98% of GP practices and in 50% of NHS trusts. | $38.1M | Series B | Sep 15, 2021 |  |
| Public | Public.com is the fractional investing platform where members build modern portfolios of stocks & ETFs, crypto & NFTs, art & collectibles. | $220M | Series D | Feb 15, 2021 |  |
| Rhino | Rhino is a licensed insurance agency that transacts insurance and gives renters financial alternatives to afford the homes they want. It is a smart alternative to security deposits and acts as a general agent for one or more insurance carriers. Rhino was founded in 2017 and is headquartered in New York, New York. | $95M | Private Equity | Jan 26, 2021 |  |
| Oscar Health | Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.It employs technology, design, and data to humanize health care. The company offers plans to individuals, couples, and families living in parts of New York, New Jersey, California, and Texas who don’t receive health insurancefrom an employer.In 2012, Joshua Kushner, Kevin Nazemi, and Mario Schlosser headquartered Oscar Health in New York, New York. | $140M |  | Dec 17, 2020 |  |

10 of 21 investments shown.

## Co-investors
- [Founders Fund](https://shizune.co/investors/profile/founders-fund) — VC Fund, 6 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 6 deals together
- [Thrive Capital](https://shizune.co/investors/profile/thrive-capital) — VC Fund, 6 deals together
- [Baillie Gifford](https://shizune.co/investors/profile/baillie-gifford) — VC Fund, 4 deals together
- [Greycroft](https://shizune.co/investors/profile/greycroft) — VC Fund, 4 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 4 deals together

## About Lakestar

VC Fund · Zürich, Switzerland

Lakestar is a venture capital firm investing in technology companies led by exceptional entrepreneurs. Early investments included Skype, Spotify, Facebook, and Airbnb. Since raising the first fund in 2013, Lakestar manages an aggregated volume of over EUR 1bn across three early-stage funds, and more recently a growth fund. The company has expandedand broadened its portfolio and holds investments in the likes of Opendoor, Oscar, GetYourGuide, Glovo, Sender, Eigen, Five, Revolut, and Hometogo to name a few. Lakestar has a presence in Berlin, Zurich, and London.Lakestar helps companies to identify new markets and expand into them rapidly, with a focus on the US and Europe. The team advises and supports portfolio companies in business development, recruitment, technology, and marketing. The investments range from early-stage companies to those in their growth stage.

5 contacts available at Lakestar.

| Name | Title | Profile |
| --- | --- | --- |
| Mathias Haniel | Partner | https://shizune.co/investors/profile/mathias-haniel |
| Mika Salmi | Managing Partner | https://shizune.co/investors/profile/mika-salmi |
| Oliver Heimes | Partner | https://shizune.co/investors/profile/oliver-heimes |
| Stephen Nundy | Partner & Chief Technology Officer | https://shizune.co/investors/profile/stephen-nundy |
| Steven Jacobs | Partner & Chief Product Officer | https://shizune.co/investors/profile/steve-jacobs-2 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Oliver Heimes invest in?

Oliver Heimes invests primarily in Health Care, Software and Medical startups, most often at Series A and Series B stage. Most of the 21 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Oliver Heimes last invest?

The most recent investment recorded for Oliver Heimes closed in Jan 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co